Bert Verbruggen

The Nijmegen Modification of the Bethesda Assay for Factor VIII:C Inhibitors: Improved Specificity and Reliability

Bert Verbruggen, I.R.O. Nováková, H. Wessels et al. · Thrombosis and Haemostasis · 1995 · 652 citations

Immunology, Pathology, M Imidazole +22

A Detailed Comparison of the Performance of the Standard versus the Nijmegen Modification of the Bethesda Assay in Detecting Factor VIII:C Inhibitors in the Haemophilia A Population of Canada

Bert Verbruggen, Georges E. Rivard, Jerome Teitel et al. · Thrombosis and Haemostasis · 1998 · 142 citations

A versatile electrowetting-based digital microfluidic platform for quantitative homogeneous and heterogeneous bio-assays

Nicolas Vergauwe, Daan Witters, Frederik Ceyssens et al. · Journal of Micromechanics and Microengineering · 2011 · 128 citations

Engineering, Analytical Microsystems, Biofabrication +25

Microfluidic analytical systems for food analysis

Yegermal Tesfaw Atalay, Steven Vermeir, Daan Witters et al. · Trends in Food Science & Technology · 2011 · 110 citations

Engineering, Food Analysis, Analytical Microsystems +4

Hyperhomocysteinemia and other thrombotic risk factors in women with placental vasculopathy

E.F. van der Molen, Bert Verbruggen, I.R.O. Nováková et al. · BJOG An International Journal of Obstetrics & Gynaecology · 2000 · 93 citations